# The GLOBAL Vitamin D Study. A Genomic, Transcriptomic, Proteomic and Metabolomic Approach

> **NCT02783924** · PHASE2 · COMPLETED · sponsor: **University of Tromso** · enrollment: 50 (actual)

## Conditions studied

- Vitamin D Deficiency

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02783924
- **Lead sponsor:** University of Tromso
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2017-09
- **Final completion:** 2018-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02783924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02783924, "The GLOBAL Vitamin D Study. A Genomic, Transcriptomic, Proteomic and Metabolomic Approach". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02783924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*